Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kimbell Royalty Partners LP Units | KRP | Jun 27, 2024 | 16.33 | +1.43 |
Kimberly-Clark | KMB | Jun 27, 2024 | 139.35 | +0.13 |
Kimco Realty | KIM | Jun 27, 2024 | 19.09 | +1.70 |
Kimco Realty L Pref | KIM-L | Jun 27, 2024 | 20.28 | +0.10 |
Kimco Realty M Pref | KIM-M | Jun 27, 2024 | 20.84 | -0.24 |
Kimco Realty Pref ADR | KIM-N | Jun 27, 2024 | 54.60 | +0.06 |
Kinder Morgan | KMI | Jun 27, 2024 | 19.76 | +0.10 |
Kindly MD | KDLY | Jun 27, 2024 | 2.79 | 0.00 |
Kineta | KA | Jun 27, 2024 | 0.57 | -1.71 |
Kinetik A | KNTK | Jun 27, 2024 | 41.19 | +1.25 |
Kingsoft Cloud ADR | KC | Jun 27, 2024 | 2.59 | -2.63 |
Kingstone Companies | KINS | Jun 27, 2024 | 4.93 | -0.20 |
Kingsway Financial Services | KFS | Jun 27, 2024 | 8.19 | +3.02 |
Kiniksa Pharmaceuticals A | KNSA | Jun 27, 2024 | 18.59 | +0.32 |
Kinross Gold | KGC | Jun 27, 2024 | 8.32 | +5.72 |
Kinsale Capital Group | KNSL | Jun 27, 2024 | 386.53 | +1.99 |
Kintara Therapeutics | KTRA | Jun 27, 2024 | 0.28 | -14.29 |
Kiora Pharmaceuticals | KPRX | Jun 27, 2024 | 4.15 | +3.75 |
Kirby | KEX | Jun 27, 2024 | 120.05 | +0.63 |
Kirklands | KIRK | Jun 27, 2024 | 1.66 | -1.19 |
Kite Realty Group Trust | KRG | Jun 27, 2024 | 22.10 | +1.66 |
KKR & Co | KKR | Jun 27, 2024 | 105.86 | +0.08 |
KKR Income Opportunities Fund | KIO | Jun 27, 2024 | 13.67 | +0.15 |
KKR Real Estate Finance Trust | KREF | Jun 27, 2024 | 9.19 | -1.50 |
KKR Real Estate Finance Trust A Pref | KREF-A | Jun 27, 2024 | 17.88 | -2.72 |
KLA | KLAC | Jun 27, 2024 | 814.87 | +0.19 |
Klaviyo | KVYO | Jun 27, 2024 | 24.87 | +6.28 |
KLD 400 Social Index Ishares | DSI | Jun 27, 2024 | 104.27 | -0.18 |
KLX Energy Services | KLXE | Jun 27, 2024 | 5.19 | +3.18 |
Knife River | KNF | Jun 27, 2024 | 70.06 | -1.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.